Lymphomation.org > 2002 Archived News Items -

2002

Please notify  
of broken links

• Emerging information on the use of rituximab in chronic lymphocytic leukemia. Semin Oncol. 2002 Feb;29(1 Suppl 2):70-4. Review. PMID: 11842391 - PubMed

• X-rays considered for carcinogen list Government move highlights cancer risk - USAToday Dec_02

• Cancer Docs Differ on Main Point of Medical Trials - Reuters Dec_27_02 

• ASH 2002: Proleukin® Plus Rituxan® may Reduce Recurrences Following Stem Cell Transplant in Non-Hodgkin’s Lymphoma - CancerConsultants.com 

• New Chemotherapy Schedule for Breast Cancer Saves Lives -  abcnews Dec_12_02  "... shorter schedule seems to give cancer cells less time to recuperate and grow between chemotherapy treatments."  Might this apply to NHL as well?

• Search ASH 2002 - abstracts (Free login req.)

• Amifostine: A Useful Radioprotectant - Oncology Review

• ASH Dec 2002 abstracts - peerviewpress.com 

• INEX achieves positive pivotal Phase II/III clinical trial results to seek FDA marketing approval for Onco TCS (liposomal vincristine) for relapsed aggressive non-Hodgkin's lymphoma (NHL). - Newswire Dec_03_02

• Is chronic lymphocytic leukemia one disease? - .haematologica.it/2002 
  "... monitoring the expression of a very limited number of genes might suffice to identify patients displaying an indolent disease from patients exhibiting an aggressive one."

• Pathogenic moulds (including Aspergillus spp.) in hospital water distribution systems: A three-year prospective study and clinical implications for patients with hematological malignancies - Blood -Nov_22_02

• Corixa Bexxar Review For Non-Hodgkin’s Lymphoma Set For Half-Day Meeting - fdaadvisorycommittee.com 12_06_02

• Treatment of cutaneous T cell lymphoma: current status and future directions. Am J Clin Dermatol. 2002;3(3):193-215. Review. PMID: 11978140 - PubMed

• Update on Epidemiology and Therapeutics for Non-Hodgkin’s Lymphoma 
  Julie M. Vose, Brian C.-H. Chiu, Bruce D. Cheson, Janet Dancey and John Wright  (Posted Nov_28_02)  Abstract  - asheducationbook.org

• Lymphoma of the Skin 
  Joseph M. Connors, Eric D. Hsi and Francine M. Foss Abstract- asheducationbook.org

• Combined therapy in advanced stages (III and IV) of follicular lymphoma increases the possibility of cure: results of a large controlled clinical trial. [in patients with nodal bulky disease] - Eur J Haematol 2002: 68: 144-149 - PDF | PDFHelp

• Future of Monoclonal Antibodies in the Treatment of Hematologic Malignancies from Cancer Control: Journal of the Moffitt Cancer Center Mitchell E. Reff, PhD, Kandasamy Hariharan, PhD, and Gary Braslawsky, PhD - Medscape (free login req.)

• Cancer Vaccines for Hematologic Malignancies from Cancer Control: Journal of the Moffitt Cancer Center Ivan M. Borrello, MD, Eduardo M. Sotomayor, MD - Medscape (free login req.)

• A comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomas - Blood Nov_21_02

• Durable Remissions Obtained with Zevalin in Recurrent Follicular Lymphoma - CancerConsultants.com Nov_8_02

• Non-AIDS-associated NHL incidence has continued to increase steadily through 1998. - J Natl Cancer Inst. 2002 Aug 21;94(16):1204-10. PMID: 12189223 - PubMed

• They can analyze thousands of genes at a time. Here's how. - techreview

• Of interest to pts with MALT: Randomized trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H pylori testing alone in the management of dyspepsia - BMJ 2002;324:999 (27 April)

• Radiation doses in computed tomography - The increasing doses of radiation need to be controlled - BMJ 2000;320:593-594 (4 March)

• Radiation dose in [CT] scans could be halved - BMJ 2001;323:185 (28 July)

• The U.S. government released its first state-by-state report on cancer - PDF  | PDF-Help This is a large 285 pg report that will take considerable time to open and print.

• NCI: Strategic Plan For Addressing the Recommendations of the Leukemia, Lymphoma, and Myeloma Progress Review Group - PDF | PDF-Help  This is important 60 page document will take a good while to open & print. Nov_2002

• Cancer Suppression Gene Identified  - HealthScoutNews Nov_16_02

• Onco TCS: first-line treatment for the aggressive form of NHL Will it replace the current standard,  CHOP + Rituxan? - INEX 11_07_2

• Cancer Patients' Attitudes Unrelated to Survival - Reuters 11_08_02

• Cancer battle can be trampoline of highs, lows - R. Clark, Pioneer Press 
  "This is going to be a hard letter for me to write," he began his e-mail. He was tipping his hand early. Turns out he had found a lump in a lymph node under his jaw while showering recently. He will have surgery Sept. 20 to remove the mass. His doctors are certain the cancer is back."

• Scientists to Study Red Wine for Anti-Cancer Drug - Reuters 11_05_02 
  "... possible new cancer prevention drug based on resveratrol, a natural compound found in red wine. "

• Early research: Vaccine 'starves cancer cells' - BBC News 11_05_02 
  Caveat: "It must be a concern if you deliver permanent immunity against the production of blood vessels."

• Study: Some Herbal Meds Interfere with Cancer Drug - Reuters 11_05_02

• Smoking May Change Type Of Lymphoma Into More Lethal Form Of Cancer - eurekalert.org 11_01_02

• ICML: Quantification of Circulating t(14;18)+ Cells Predicts Response to Rituximab Therapy in Follicular Lymphoma Patients - Docguide.com 6_18_02

• Psychological Stress Does Not Cause Cancer: Study - Reuters 10_30_02

• NCI Initiates Trial of Genasense(TM) Plus Rituxan In Patients With Non-Hodgkin's Lymphoma - Prnewswire 10_30_02
  From Prnewswire, use Search button and key word Genasense to locate.

• How many Cts are too many? Putting long-term risks into perspective - Update 10_29_02

• Scientists have found a way to harvest more stem cells from a baby's umbilical cord. - BBC News 10_22_02

• Regular exercise could both help people avoid developing cancer, or help them make a more successful recovery, say scientists - BBC News 10_18_02

• Rituximab as First-Line and Maintenance Therapy for Patients With Indolent Non-Hodgkin's Lymphoma. J Clin Oncol. 2002 Oct 15;20(20):4261-7.
  PMID: 12377971 - PubMed

• Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells vs. bone marrow in allogeneic recipients: long-term follow-up of a randomized trial - Blood, 15_July_2002 (lost link)

• Smallpox vaccine & NHL: Information on Live Virus Vaccines and Vaccinia - cdc.gov  | Also see  Immunization guide  

• Magnetic Resonance Imaging of the Bone Marrow in Hematologic Malignancies - Blood, Vol. 90 No. 6 9_15_97

• Zevalin Safe For Patients Who Have Had Prior Radiation - OncoLink 
  10-9-02 2002

• Sequencing of Therapies for Low-Grade Lymphomas - cancercare.org 
  Presenter: Peter Rosen, MD, Professor of Medicine, UCLA School of Medicine, Department of Hematology and Oncology, Los Angeles, CA.

• OVERCOMING REFRACTORY DISEASE: Bendamustine in the treatment of non-Hodgkin's lymphoma: results and future perspectives. Semin Oncol. 2002 Aug;29(4 Suppl 13):27-32. Review. PMID: 12170430 - PubMed

• FDA Launches Plan to Reduce Acrylamides in Foods, - Reuters 9-30-02

• Evaluation of the Risk of Therapy-Related MDS/AML After Autologous Stem Cell Transplantation  - HTML Biology of Blood and Marrow Transplantation 8:9-16 (2002)

• Response to thalidomide in chemotherapy-resistant mantle cell lymphoma: a case report. Br J Haematol. 2002 Oct;119(1):128-30.
  PMID: 12358916 - PubMed

• Mini Transplants Appear Effective for Some Patients who Relapse Following Autologous Stem Cell Transplants - CancerConsultants.com 10-07-02

• Subsequent Therapy Well Tolerated in Patients Previously Treated with 
  Zevalin (tm) - 411cancer.com Sep_02

• How to disinfect your salad -  Dianne Peters of the Univ. of Nebraska-Lincoln Sep_96 

• Rare Disorder Provides New Insight Into Fighting Infection - NIH Sep_25
  "Caspase-8 deficiencies might explain why some people don't respond as well as others to vaccines, or why some people's immune systems don't fight off infections as well as others."

• Rituxan + steriods:  Glucocorticoids and rituximab in vitro: synergistic direct antiproliferative and apoptotic effects. Blood. 2002 Sep 1;100(5):1765-73. PMID: 12176898 - PubMed

• Sewage Yields Clues to SV40 Transmission -  JAMA Sep_18

• Photopheresis Followed by Immunotherapy Improves Responses in Cutaneous T-Cell Lymphoma  - 411cancer.com

• Cancer Cells Killed in Test Therapy - Health AP

• Fact Sheet: West Nile Virus Infection in Organ Transplantation and Blood
  Transfusion Recipients - cdc.gov

• GenOdyssee Announces Positive Results of Proprietary Interferon-alpha Variants for the Treatment of Hepatitis C and Cancer - Sep_05
  - In Preclinical Disease Models Variants Demonstrate Increased Efficacy Compared to Those Currently Available on the Market - nrp-euro.com 

• Immunological and molecular analysis of B lymphocytes in low-grade MALT lymphoma of the stomach. Are there any useful markers for predicting outcome after Helicobacter pylori eradication? J Gastroenterol. 2002;37(6):428-33. PMID: 12108676 - PubMed

• Cancer Vaccines for Hematologic Malignancies: Ivan M. Borrello, MD, Eduardo M. Sotomayor, MD - Medscape Free login req.

• Oxaliplatin Appears Effective (as cisplatin) in Treatment Regimen for Recurrent NHL - CancerConsultants.com  "This news item was actually published in December, but we posted it recently because oxaliplatin was just FDA approved for colorectal cancer."

• Monoclonal Antibody Therapy in B-Cell-Related Disorders and Malignancies CME  Authors: Sandra J. Horning, MD and Robert S. Mocharnuk, MD - Medscape free login req.

• Optimizing Anti-CD20 Immunotherapy of Lymphomas and Chronic Lymphocytic Leukemia, D. G. Maloney, MD, PhD,  R. Mocharnuk, MD  - iwmf.com

• Phase II trial of interferon-alpha-2a plus psolaren with ultraviolet light A in patients with cutaneous T-cell lymphoma. Cancer 2002; 95: 569-75. -  PubMed

• Immune Factors May Influence Post-Cancer Fatigue - Reuters Sep_2

• Enhanced killing of B lymphoma cells by granulocyte colony-stimulating factor-primed effector cells and Hu1D10 - a humanized human leucocyte antigen DR antibody. Br J Haematol. 2002 Sep;118(4):959-67.
  PMID: 12199773 - PubMed

• Red Wine Consumption Associated with Reduced Risk of Non-Hodgkin's Lymphoma - 411cancer.com Aug_2

• High-Dose Chemotherapy and Autologous Stem Cell Transplantation Improves Responses in Advanced Follicular Lymphoma  - 411cancer.com Aug_2

• Zevalin (tm) Effective in Recurrent Follicular Lymphoma - 411cancer.com

• Lymphoma and Pregnancy - David B. Miklos M.D., Ph.D. (Verites)

• Recommended reading: NHL-specific "When to Consider a Clinical Trial" - Dr. David B. Miklos M.D., Ph.D.  (Verites)

• St John’s wort interferes with chemotherapy, study shows - BMJ Aug_31

• Clinical trials specific to Diffuse Large Cell Lymphoma - New Content on PAL Aug_28

• Management of Cancer in the Elderly -  mmhc.com

• Report Cites 'Dangerous' Cancer Advice on Web - Reuters Aug_20

• St. John's Wort Weakens Cancer Drug's Effect - Reuters Aug_20

• Scientific presentations vary from 35-60 minutes in length. They provide research reviews usually given at the Moffitt Cancer Center facility.  - H. Lee Moffitt Cancer Center & Research Institute Req. Windows Media Player

• Use of Complementary/Integrative Nutritional Therapies During Cancer Treatment: Implications in Clinical Practice - Medscape 2002 H. Lee Moffitt Cancer Center and Research Institute, Inc.

• Intrathecal Chemotherapy may Reduce Cancer Recurrences in Aggressive Non-Hodgkin's Lymphoma -  411cancer.com Aug_02

• Low-Dose Radiation plus Donor Lymphocyte Infusion Produces Responses in Refractory Hematologic Cancers - 411cancer.com Aug_02

• New Links Between Cancer and Gene p27 - Oncology News Aug_6

• Clinical trial participation is crucial to fight cancer - SHERRY LANSING AND NORMAN SCHWARZKOPF Jul_26 - Pioneer Press

• Phase II immunotherapy trial launched in CLL: a Phase II immunotherapy trial with Tragen Pharmaceuticals' lead product, ISF154, has been launched in chronic lymphocytic leukaemia (CLL) - press release

• FDA Grants Orphan Drug Status to Oncophage® Vaccine for Metastatic Melanoma - CancerConsultants.com

• Advantages of positron emission tomography (PET) with respect to computed tomography in the follow-up of lymphoma patients with abdominal presentation. Leuk Lymphoma. 2002 Jun;43(6):1239-43. PMID: 12152991- PubMed

• Cancer treatments now come in pill form  -  Philadelphia Inquirer Aug_5

• Controversy hides drug's advantages St. Petersburg Times July_30
  ImClone's insider trading scandal has drawn more attention than its promising cancer treatment has.

• Progress and promise in the treatment of indolent lymphomas.
  Oncologist. 2002;7(3):217-25. Review. PMID: 12065794 - PubMed

• Tobacco as Cancer Research Tool : Plants Aid in Development of a Vaccine to Fight Tumors - By Justin Gillis Washington Post Staff Writer July_22_2002

• SV40 virus UPDATES - SLIDES & PRESENTATIONS : SV40 Contamination of Polio Vaccine and Cancer Meeting Agenda - PAL Presentations by experts July 11, 2002 National Academy of Sciences 

• CLINICAL TRIALS UPDATE: Quickly find NHL-specific clinical trial listings from the ClinicalTrials.gov database - PAL 7_23 Locate trials by treatment type, or for many other criteria with just one click.

• Dying Cancer Patients Want Straight Info from Docs - Reuters  Jul_22

• US Government, Industry Move to Speed Cancer Trials - Reuters Jul_23

• FDA APPROVES AMGEN'S ARANESP™ FOR ANEMIA ASSOCIATED WITH CHEMOTHERAPY - PR Newswire Jul_22

• Wall Street Journal reports on SV40 virus connection to NHL.  See SV40 virus issues updates.  7_22_02 "In several tumors, it was precisely the genome of the SV40 in the vials of the 1955 polio vaccine that Dr. Ratner had held onto, waiting for someone to care. Lab-grown SV40 harbors a variant genome. There might be other sources, in addition to vaccine, of this strain of SV40, but to more and more scientists Dr. Butel's findings were the smoking gun." - WSJ 7-19-02

• Anti-Cancer Compound Found in Malaysian Plant (Eurycoma longifolia)  - Reuters 7_22 Related Abstracts

• NEW TREATMENT AGENT: GENTA INITIATES NEW CLINICAL PROGRAM FOR GALLIUM NITRATE IN NON-HODGKIN’S LYMPHOMA - Genta "An important property of gallium is that it appears to display preferential targeting to lymphoma cells and, unlike most chemotherapeutic drugs, it does not suppress the bone marrow."

• The Fight to Keep 'Direct-to-Consumer Ads' for drugs - NY_Times Jul_12
  PAL Note: Does this kind of promotion drain financial resources away from development of drugs to treat life threatening cancers? Does it increase incentives to develop more "me-too" drugs of questionable value?

• Cancer Patients Get Inadequate Care for Pain: Panel - Reuters Jul_17

• Health Info on Web Often Not Backed by Science - Reuters Jul_16

• RESEARCH: Beyond immunochemotherapy: combinations of rituximab with cytokines interferon-alpha2a and granulocyte-macrophage colony stimulating factor. Semin Oncol. 2002 Apr;29(2 Suppl 6):7-10. Review. PMID: 12040528 - PubMed

• US Panel Says No Amount of Trans Fat Is Safe - Reuters Jul_15
  Note: Trans fats have been linked to increased risk of NHL - PAL

• Many Cancer Patients Use Complementary Therapies - Reuters July_15

• ANEMIA RECOMMENDATION: Management of disease-related anemia in patients with multiple myeloma or chronic lymphocytic leukemia: epoetin treatment recommendations. Hematol J. 2002;3(3):121-30. PMID: 12111647 - PubMed

• DRUG TOXICITY INFO: Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study. Cancer Chemother Pharmacol. 2002 Jul;50(1):37-45. PMID: 12111110 - PubMed

• DRUG INFO: Splenic lymphoma in presence of HCV may respond to interferon alpha - Reuters Health Jul_10

• RESEARCH NEWS: Cytokine improves immune function after bone marrow transplantation in mice - Reuters Health

• RESEARCH NEWS: Simian 40 virus seen as entrenched in humans, but oncogenicity disputed  - Reuters Health Jul_11

• ALERT: J&J WARNS OF RARE BLOOD DISORDER RISK FROM EPREX
  Johnson & Johnson on Thursday said the number of patients who have developed a rare blood disorder when treated with the firm's anemia drug has risen to 124 worldwide and 1 of those patients died. Reuters Health Information 2002 - Medscape

• FEW LEUKEMIC CHILDREN DEVELOP SECOND NEOPLASMS
  Follow-up of children successfully treated for acute Lymphoblastic leukemia (ALL) indicates that the incidence of second neoplasms is low.
  Reuters Health Information 2002 - M July_11

• RESEARCH ABSTRACT: Fully human, HLA-DR-specific monoclonal antibodies efficiently induce programmed death of malignant lymphoid cells. Nat Med. 2002 Jul 8 PMID: 12101408 - PubMed

• RESEARCH PRESS: Cancer research focuses on tumors' DNA  -  By Raja Mishra, Globe Staff, July_8 

• DRUG INFO: Full Prescribing Information - Zevalin: IDEC | Rituxan: - IDEC

• DRUG INFO: Zevalin Reimbursement Support - IDEC
  Information on how to navigate through the complex maze of health insurance requirements

• RESEARCH PRESS: Scientists may be on the verge of curing some of the most deadly and crippling diseases that plague man, experts said Sunday during MSNBC TV’s “Summit for a Cure.” - MSNBC Jun_24

• DRUG NEWS: FDA grants Corixa's appeal for BEXXAR® - Corixa
  Corixa to present BEXXAR data at future ODAC meeting Jun_26

• DRUG DATA: Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy. Blood. 2002 Apr 15;99(8):2685-93. PMID: 11929754 - PubMed

• Technical: Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells," Journal of Experimental Medicine - PDF | PDF-Help

• Product R, a "switch type" immunomodulator, will be tested in lymphoma pts with symptoms of cachexia  - Oncology News Jun_17

• Inhibitor of the enzymatic activity of telomerase (GRN163) active against Myeloma and Lymphoma - Oncology News Jun_18

• Rituximab (especially extended use) Delays Indolent NHL Progression - Oncology News Jun_18

• PET Scans Better Than Standard Gallium Scan - ACS News Today Apr_2002

• Investigational Data From Randomized Study of Extended Therapy With Rituxan Demonstrates Potential to Delay Disease Progression in Patients With Indolent NHL - Genentech Jun_17

• The Psychology of Cancer By: Harvey Max Chochinov, MD, PhD By: Sherry Schachter, PhD, RN - Healthology Jun_18

• Mantle Cell treatment effective - BBCNews Jun_17

• ALERT: The Leukemia & Lymphoma Society is warning pts and
  healthcare professionals to avoid using a counterfeit lot of PROCRIT brand of epoetin alfa, a drug used to treat anemia. For more information, please visit www.procrit.com/counterfeit/letter.html or call the Society's Information Resource Center at (800) 955-4572, 9 a.m. to 6 p.m. EST, Monday to Friday.

• Officials Press U.S. Congress for Cancer Tracking - Press Jun_13
  "WASHINGTON (Reuters Health) - Public health officials pushed the US Congress Thursday to approve plans for a nationwide disease tracking system designed to detect cancer clusters and other disease outbreaks possibly caused by environmental toxins."

• Automating patients-specific treatment: Favrille sets sights on Rituxan - Press release Jun_14

• 'Trojan horse' technology destroys blood supply to cancer tumors in mice - eurekalert.org "Researchers at The University of Texas M. D. Anderson Cancer Center in Houston and The University of Texas Southwestern Medical Center at Dallas have demonstrated in mice that a new drug formed by linking a vascular endothelial growth factor to a toxin will target and destroy the blood vessels supplying a malignant tumor.

• Scientists Become Filmmakers to Decipher Immunity - NIAID
  "According to Dr. Germain, the new technique will permit investigators to explore questions they previously could not clearly address: for example, how long do T cells remain in contact with their target cells, when do the T cells divide, and where do different types of T cells go once they have been activated."

• Epoetin therapy is effective against anemia - Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin Beta, in hematologic malignancies. J Clin Oncol. 2002 May 15;20(10):2486-94. PMID: 12011126 abstract

• The FDA has amended its new drug and biological product regulations so that certain human drugs and biologics that are intended to reduce or prevent serious or life-threatening conditions may be approved for marketing based on evidence of effectiveness from appropriate animal studies when human efficacy studies are not ethical or feasible. Summary |  PDF | PDF-Help

• Immunotherapy Shows Promise for Non-Hodgkin's Lymphoma - Medscape May_20 "The goal is really to delay or prevent the need for chemotherapy," said study author Dr. John Timmerman, an assistant professor of medicine at the University of California, Los Angeles.

• Patients in cancer drug plea Tuesday, 28 May, 2002 - news UK

• Viral Origins of Lymphoma - MD Anderson Oncolog

• Occupation and risk of non-Hodgkin's lymphoma and chronic lymphocytic leukemia. J Occup Environ Med. 2002 May;44(5):469-74. PMID: 12024692 PubMed abstract

• What Are Clinical Trials For?  - Oncology News May_22
  "The researchers stated that these findings suggest that there is a "provocative view in oncology that clinical trials perfectly harmonize the objectives of treatment and research." Further, they stated that the conviction that studies are directed mainly to benefit participants challenges the commonly held opinion that research is conducted for scientific knowledge and the improvement of therapy given in the future."

• RADIO-IMMUNOTHERAPY: NEW DEVELOPMENTS IN LYMPHOMA TREATMENT, by Julie Vose, MD  a free teleconference, Tuesday June 18, 2002, 1 PM-2 PM ET.   For more info call 1800 813-HOPE or (212) 712-8080 or register online at www.cancercare.org

• UNDERSTANDING CANCER PATIENTS' NEEDS, CONCERNS IS KEY TO IMPROVING CLINICAL TRIAL PARTICIPATION - UC Davis CC May_20

• Immunomedics Announces Additional Interim Results of Epratuzumab Combination In Treating Non-Hodgkin's Lymphoma - PR Newswire May_20

• Experimental Therapy, End-of-Life Care Can Coexist
  Tue May 21, 7:12 PM ET -  HealthScoutNews
  "In the past, it's been an either-or situation: Seriously ill patients have been told they can have a clinical trial or they can go home and focus on quality of life,"

• The All-Cancer Film Festival - "A patient in chemotherapy surveys the genre."  By Gary Sperling - culturebox May_20

• Solving The Drug Patent Problem - Forbes May_21

• FDA Continues Bexxar Approval Quest  May_16
  Officials from Corixa recently met with representatives from the US Food and Drug Administration about the company's biologics license application for tositumomab (Bexxar) as a treatment for relapsed, refractory non-Hodgkin's lymphoma.

• Unresponsive NHL Patients Respond to Zevalin  May_13
  Scientists at the Mayo Clinic reported that patients diagnosed with non-Hodgkin's lymphoma who did not respond to standard treatment responded to ibritumomab (Zevalin)

• Bush Signs Blood Cancer Research Bill  May_14
  President George W. Bush signed a bill on May 14 ... 

• STILL VITAL: BLOOD CANCER ADVOCACY ACTION: Write! e-mail Letter - LRF -- This EASY action sends a prewritten letter to all your representatives in one step. PLEASE HELP by clicking the link above.  NOTE: Be sure to click in and edit  the paragraphs in each letter to describe your personal connection (patient, caretaker, loved one).

• Cancer Treatment: Determining the Best Long-Term Plan for You - PDF | PDF-Help - Maloney, Cha  (Highly recommended. Requires Adobe Acrobat reader.)

• Pediatric non-Hodgkin's lymphoma: clinical and biologic prognostic factors and risk allocation. Curr Oncol Rep. 2002 Mar;4(2):107-13. Review.

• Microtubules and New Drug Therapies - Source: Molecular Cell May_6

• Can cancer drug heal Millennium? Biotech firm betting on experimental drug to revive hopes press release May_3 (potential NHL drug - PS 341)

• SV40 virus found in human lymphoma samples eurekalert | cancerfacts | Lancet  - Presence of SV40 DNA sequences in specific lymphomas.rtf 

• Blood cancer efforts get lift -- Hutchison's bill to aid research heads to White House press release apr_30

• Using Antisense, Monoclonal, and Standard Chemotherapy All Together - BioNews "Genta (NASDAQ: GNTA) announced the initiation of a multicenter clinical trial in patients with mantle cell lymphoma (MCL)" Feb 2002

• Cancer Risk Found in French Fries, Bread - Reuters Apr_24
  "Findings unveiled at a news conference called by the food administration showed that an ordinary bag of potato chips may contain up to 500 times more of the substance (acrylamide)  than the top level allowed in drinking water by the World Health Organization"

• Clinical trials: They're Dying to Get In - Time Apr_24

• Clinical trials: Questions to Ask Your Doctor & More Resources - Time Apr_24

• Higher incidence of cancer seen in young adults: Report Last Updated Thu, 18 Apr 2002 19:10:38 - TORONTO press release  "non-Hodgkin's lymphoma increased 3.5 per cent among women and 4.0 per cent among per year" Apr_18

• Despite Billions for Discoveries, Pipeline of Drugs Is Far From Full - press Apr_19 

• Patient-Doc Communication Key to Cancer Pain Relief - press

• Cancer Vaccine Shows Promise Against Brain (and other) Tumor - press release " . . .  the concept is that you could take a human tumor, engineer that, flagging it somehow, and then injecting it back into the human to trigger an immune response" Apr_16

• Getting Used to Life, Long Life, With Cancer - NY Times Reg req.
  "Some with cancer say that, if you want to know what it's like to be given a diagnosis of a serious malignancy, think of Sept. 11. "On that day, 280 million Americans had the same sense of shock and disbelief that a person feels when told they have cancer," said the woman with lymphoma, who asked to remain anonymous. "You feel that it can't be happening, it can't be real." In a single day, she said, "your innocence is lost and your sense of security shattered," and regardless of what happens, it will never be Sept. 10 again." Apr_16

• Cancer Patients Need Weight Kept On - AP press Apr_11

• Drug (phenoxodiol) stabilizes cancer growth minus side effects - CNN.com Health Apr_11

• Anti-idiotypic vaccination in the treatment of low-grade B-cell lymphoma - Haematologica 2002 Apr;87(4):400-7 abstract

• Rituxan as frontline treatment "With further follow-up and repeat courses of rituximab, the major response rate increased from 47% to 65% and the complete response rate increased from 7% to 27%."  - Semin Oncol 2002 Feb;29(1 Suppl 2):25-9 abstract

• AP23573, shrinks tumors in MICE by interrupting the metabolism of cancer cells and disrupting their ability to take in nutrients like carbon and nitrogen. press release Apr_9

• Modulating apoptosis pathways in low-grade B-cell malignancies using biological response modifiers. (Rituxan, TRAIL, retinoid/steroid family nuclear receptors, inhibitors of protein kinases.) T Semin Oncol 2002 Feb;29 abstract

• New Studies Show Genasense Potentiates Anticancer Actions of Taxotere and Rituxan - Genta Inc 4-08

• Genetic characteristics  predict response to Rituxan? -Blood 2002 Feb 1 abstract

• Dynavax Initiates First Human Trial Of ISS Immunotherapy And Rituxin® (Rituximab) press release

• An hour's exposure to a commonly used crop pesticide could render your immune system defenseless.  American Chemical Society - press release HealthScout 4-08

• Physician Heal Thyself: "Jane Wardle knew all about the theory of coping with cancer - she's a psychologist whose specialty is helping patients with the disease. Then one day she was told that she had leukemia."

• Antiangiogenesis update: "The first in vivo screening of a peptide library of the human vasculature opens new possibilities for inhibiting angiogenesis and tumor growth." - Cancer Cell, Folkman (Thanks, Scott)